Plain-English translation of NCT07618481 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called a brain-computer interface combined with 40Hz audio-visual stimulation — which means using special equipment to deliver coordinated light and sound at a specific frequency to your brain. The goal is to see whether this treatment can help improve memory, thinking, and other cognitive abilities in people with Alzheimer's disease. Researchers will compare three groups: one receiving the full treatment, one receiving a personalized version that adjusts in real time based on your brain activity, and one receiving a placebo (inactive) version.
Alzheimer's disease gradually damages memory and thinking abilities, and current treatments are limited. This trial exists to explore whether a new approach using coordinated brain stimulation might slow cognitive decline or help preserve brain function better than what we have today.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive 60-minute treatment sessions once daily for 6 consecutive months. Depending on which group you are randomly assigned to, you will either receive fixed-frequency stimulation, personalized stimulation that adjusts based on your brain waves, or a placebo version. Throughout the study, you will have cognitive testing, brain imaging scans, and blood tests to measure how the treatment affects your thinking, brain activity, and Alzheimer's biomarkers. You will also be monitored for any side effects or safety concerns.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China